Evidence map›Paper›PMID 37419768›Full record

Trial reportExplore (New York, N.Y.)

Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: A prospective, randomized, double-blind multicenter study.

Lobna Mahjoub, Rym Youssef, Hajer Yaakoubi, Houda Ben Salah, Rahma Jaballah, Moez Mejri, Adel Sekma, Imen Trabelsi, Semir Nouira, Mariem Khrouf and 5 more

Open access · greenAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Explore (New York, N.Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Lobna MahjoubEmergency Department, Sahloul University Hospital, 4011 Sousse, Tunisia.
Rym YoussefEmergency Department, Sahloul University Hospital, 4011 Sousse, Tunisia.
Hajer YaakoubiEmergency Department, Sahloul University Hospital, 4011 Sousse, Tunisia.
Houda Ben SalahEmergency Department, Sahloul University Hospital, 4011 Sousse, Tunisia.
Rahma JaballahEmergency Department, Sahloul University Hospital, 4011 Sousse, Tunisia. Electronic address: jaballahrahma27@gmail.com.
Moez MejriEmergency Department, Sahloul University Hospital, 4011 Sousse, Tunisia.
Adel SekmaResearch Laboratory LR12SP18, Monastir University, 5019 Tunisia.
Imen TrabelsiResearch Laboratory LR12SP18, Monastir University, 5019 Tunisia.
Semir NouiraResearch Laboratory LR12SP18, Monastir University, 5019 Tunisia.
Mariem KhroufEmergency department, Farhat Hached University Hospital, 4031 Sousse, Tunisia.
Houda Ben SoltaneEmergency department, Farhat Hached University Hospital, 4031 Sousse, Tunisia.
Zied MezgarEmergency department, Farhat Hached University Hospital, 4031 Sousse, Tunisia.
Lotfi BoukadidaEmergency Department, Sahloul University Hospital, 4011 Sousse, Tunisia.
Asma ZorgatiEmergency Department, Sahloul University Hospital, 4011 Sousse, Tunisia.
Riadh BoukefEmergency Department, Sahloul University Hospital, 4011 Sousse, Tunisia.
Hôpital Sahloul · TNHôpital Farhat Hached · TNUniversity of Monastir · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMelatonin, zinc, and multivitamins are among most recommended supplements in the fight against coronavirus disease 2019 (COVID-19). We aimed to examine the efficacy and safety of this association in the treatment of COVID-19 and COVID-like illnesses.

methodsWe conducted a multicenter prospective, randomized, double-blind, controlled trial. Patients with no medical history consulting the emergency department for covid and covid-like illness and who were not hospitalized were included. Patients were assigned in a 1:1 ratio to the treatment or the placebo group. The primary outcome was studying the effectiveness of zinc multivitamin supplement and melatonin in the treatment of COVID and -like illnesses symptoms' according to the time from randomization to clinical improvement. The pre-specified secondary outcomes were date of disappearance of symptoms present on admission, appearance of an adverse effect due to the administration of the treatment, number of patients developing complications, requiring hospitalization, requiring respiratory support.

resultsOne hundred sixty four patients were eligible for the study and were randomized to either the treatment group or the placebo group. Overall, 128 of the 164 patients had a PCR for SARS-CoV-2, yielding a positive PCR result in 49.1% of them. Regarding the disappearance of all initial presenting symptoms: on the

conclusionsOur results showed that daily doses of Melatonin, zinc and vitamins did significantly reduce the duration of symptoms accelerating its disappearance among patients consulting with COVID-19 or COVID-19 like illness.

Indexed as

COVID-19MelatoninHumansMineralsProspective StudiesSARS-CoV-2Treatment OutcomeVitaminsZincMelatoninMineralsVitaminsZincCovid-19Emergency departmentMelatoninVitamin CVitamin DZinc

Identifiers

PMID37419768
PMCPMC10281695
OpenAlexW4381331893

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.